Chairman & Chief Executive Officer, Medpace Holdings
Search every verified August Troendle interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. In a 2017 interview, August Troendle, founder and CEO of Medpace, discussed the company's founding and approach to drug development. Troendle stated that he founded Medpace because he believed drug development "should be done by experts in drug development." He described Medpace as a full-service contract research organization (CRO) that focuses on internal expertise before launching into a therapeutic area, naming cardio metabolic and oncology as the largest areas by volume, while also noting expertise in areas such as AVAI and CNS. Troendle addressed the role of company size in conducting large-scale studies, stating he does not see size as a differentiating factor for Medpace versus other companies. He noted that while the largest programs might require 50 full-time employees, Medpace has 1,700 globally, and asserted that "there are no programs that are too large." He emphasized that Medpace sticks to a full-service model and seeks companies looking for external expertise, aiming to hone its systems and processes around providing that expertise.
“I thought that drug development should be done by experts in drug development and that's what Medpace should become.”
“In any of the therapeutic areas in which we operate, we look towards internal expertise and capabilities before we've launched a therapeutic area.”
“The largest therapeutic areas by volume that we operate in would be cardio metabolic and oncology, but we have great expertise in AVAI, CNS, and elsewhere.”
“I don't really see size as being a differentiating factor and certainly not for us versus other companies.”
“The largest programs might have 50 full-time employees required and we have 1,700 globally; there are no programs that are too large.”
“We do stick to full-service and source and we do look for companies that are looking for external expertise; we build upon that and we need to hone our systems and processes around providing full-service expertise.”
Dr. August Troendle, Medpace founder and CEO talks about Medpace capabilities to conduct therapeutically focused, studies.
Sign in to search the full transcript archive, filter by topic, and access every quote from August Troendle.
The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →